Literature DB >> 30514770

Functional and behavioral consequences of Parkinson's disease-associated LRRK2-G2019S mutation.

Deanna L Benson1, Bridget A Matikainen-Ankney2, Ayan Hussein2, George W Huntley2.   

Abstract

LRRK2 mutation is the most common inherited, autosomal dominant cause of Parkinson's disease (PD) and has also been observed in sporadic cases. Most mutations result in increased LRRK2 kinase activity. LRRK2 is highly expressed in brain regions that receive dense, convergent innervation by dopaminergic and glutamatergic axons, and its levels rise developmentally coincident with glutamatergic synapse formation. The onset and timing of expression suggests strongly that LRRK2 regulates the development, maturation and function of synapses. Several lines of data in mice show that LRRK2-G2019S, the most common LRRK2 mutation, produces an abnormal gain of pathological function that affects synaptic activity, spine morphology, persistent forms of synapse plasticity and behavioral responses to social stress. Effects of the mutation can be detected as early as the second week of postnatal development and can last or have consequences that extend into adulthood and occur in the absence of dopamine loss. These data suggest that the generation of neural circuits that support complex behaviors is modified by LRRK2-G2019S. Whether such alterations impart vulnerability to neurons directly or indirectly, they bring to the forefront the idea that neural circuits within which dopamine neurons eventually degenerate are assembled and utilized in ways that are distinct from circuits that lack this mutation and may contribute to non-motor symptoms observed in humans with PD.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  behavior; cellular activity; leucine-rich repeat kinase; stress; synapses; synaptic plasticity

Mesh:

Substances:

Year:  2018        PMID: 30514770      PMCID: PMC6311993          DOI: 10.1042/BST20180468

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  68 in total

Review 1.  Structural and synaptic plasticity in stress-related disorders.

Authors:  Daniel J Christoffel; Sam A Golden; Scott J Russo
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

2.  LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.

Authors:  Maria Nguyen; Dimitri Krainc
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

3.  A standardized protocol for repeated social defeat stress in mice.

Authors:  Sam A Golden; Herbert E Covington; Olivier Berton; Scott J Russo
Journal:  Nat Protoc       Date:  2011-07-21       Impact factor: 13.491

4.  LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism.

Authors:  Amaia M Arranz; Lore Delbroek; Kristof Van Kolen; Marco R Guimarães; Wim Mandemakers; Guy Daneels; Samer Matta; Sara Calafate; Hamdy Shaban; Pieter Baatsen; Pieter-Jan De Bock; Kris Gevaert; Pieter Vanden Berghe; Patrik Verstreken; Bart De Strooper; Diederik Moechars
Journal:  J Cell Sci       Date:  2015-02-01       Impact factor: 5.285

5.  LRRK2 regulates synaptic vesicle endocytosis.

Authors:  Narae Shin; Hyerhan Jeong; Jungsun Kwon; Hye Young Heo; Jung June Kwon; Hye Jin Yun; Cy-Hyun Kim; Baek Soo Han; Youren Tong; Jie Shen; Taku Hatano; Nobutaka Hattori; Kwang-Soo Kim; Sunghoe Chang; Wongi Seol
Journal:  Exp Cell Res       Date:  2008-03-05       Impact factor: 3.905

6.  G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons.

Authors:  Laura A Volpicelli-Daley; Hisham Abdelmotilib; Zhiyong Liu; Lindsay Stoyka; João Paulo Lima Daher; Austen J Milnerwood; Vivek K Unni; Warren D Hirst; Zhenyu Yue; Hien T Zhao; Kyle Fraser; Richard E Kennedy; Andrew B West
Journal:  J Neurosci       Date:  2016-07-13       Impact factor: 6.167

7.  Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease.

Authors:  Xianting Li; Qing Jun Wang; Nina Pan; Sangkyu Lee; Yingming Zhao; Brian T Chait; Zhenyu Yue
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

8.  Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.

Authors:  Tonya N Taylor; Dawid Potgieter; Sabina Anwar; Steven L Senior; Stephanie Janezic; Sarah Threlfell; Brent Ryan; Laura Parkkinen; Thierry Deltheil; Milena Cioroch; Achilleas Livieratos; Peter L Oliver; Katie A Jennings; Kay E Davies; Olaf Ansorge; David M Bannerman; Stephanie J Cragg; Richard Wade-Martins
Journal:  Neurobiol Dis       Date:  2013-10-10       Impact factor: 5.996

9.  Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.

Authors:  Martin Steger; Francesca Tonelli; Genta Ito; Paul Davies; Matthias Trost; Melanie Vetter; Stefanie Wachter; Esben Lorentzen; Graham Duddy; Stephen Wilson; Marco As Baptista; Brian K Fiske; Matthew J Fell; John A Morrow; Alastair D Reith; Dario R Alessi; Matthias Mann
Journal:  Elife       Date:  2016-01-29       Impact factor: 8.140

10.  The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.

Authors:  Rafeeq Mir; Francesca Tonelli; Pawel Lis; Thomas Macartney; Nicole K Polinski; Terina N Martinez; Meng-Yun Chou; Andrew J M Howden; Theresa König; Christoph Hotzy; Ivan Milenkovic; Thomas Brücke; Alexander Zimprich; Esther Sammler; Dario R Alessi
Journal:  Biochem J       Date:  2018-06-06       Impact factor: 3.857

View more
  6 in total

1.  LRRK2 and GBA Variants Exert Distinct Influences on Parkinson's Disease-Specific Metabolic Networks.

Authors:  Katharina A Schindlbeck; An Vo; Nha Nguyen; Chris C Tang; Martin Niethammer; Vijay Dhawan; Vicky Brandt; Rachel Saunders-Pullman; Susan B Bressman; David Eidelberg
Journal:  Cereb Cortex       Date:  2020-05-14       Impact factor: 5.357

2.  Altered Motor Performance, Sleep EEG, and Parkinson's Disease Pathology Induced by Chronic Sleep Deprivation in Lrrk2G2019S Mice.

Authors:  Xinyao Liu; Hang Yu; Yuanyuan Wang; Song Li; Cheng Cheng; Murad Al-Nusaif; Weidong Le
Journal:  Neurosci Bull       Date:  2022-05-25       Impact factor: 5.271

Review 3.  LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic Insights.

Authors:  Patrick D Skelton; Valerie Tokars; Loukia Parisiadou
Journal:  Cells       Date:  2022-01-05       Impact factor: 7.666

4.  Inhibition of LRRK2 kinase activity promotes anterograde axonal transport and presynaptic targeting of α-synuclein.

Authors:  Charlotte F Brzozowski; Baraa A Hijaz; Vijay Singh; Nolwazi Z Gcwensa; Kaela Kelly; Edward S Boyden; Andrew B West; Deblina Sarkar; Laura A Volpicelli-Daley
Journal:  Acta Neuropathol Commun       Date:  2021-11-08       Impact factor: 7.801

5.  Aberrant Patterns of Sensory-Evoked Activity in the Olfactory Bulb of LRRK2 Knockout Mice.

Authors:  Andrea Maset; Marco Albanesi; Antonio di Soccio; Martina Canova; Marco Dal Maschio; Claudia Lodovichi
Journal:  Cells       Date:  2021-11-17       Impact factor: 6.600

Review 6.  From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson's Disease: Lessons From LRRK2.

Authors:  Andrea Mancini; Petra Mazzocchetti; Miriam Sciaccaluga; Alfredo Megaro; Laura Bellingacci; Dayne A Beccano-Kelly; Massimiliano Di Filippo; Alessandro Tozzi; Paolo Calabresi
Journal:  Front Cell Neurosci       Date:  2020-07-28       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.